Prevalence of hypermutator isolates of Achromobacter spp. from cystic fibrosis patients

被引:9
|
作者
Ridderberg, Winnie [1 ]
Handberg, Kurt Jensen [1 ]
Norskov-Lauritsen, Niels [1 ]
机构
[1] Aarhus Univ Hosp, Dept Clin Microbiol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark
关键词
Hypermutation; Cystic fibrosis; Achromobacterspp; Chronic infection; PSEUDOMONAS-AERUGINOSA; MISMATCH REPAIR; STENOTROPHOMONAS-MALTOPHILIA; MOLECULAR CHARACTERIZATION; GENETIC ADAPTATION; HIGH-FREQUENCY; XYLOSOXIDANS; INFECTIONS; STRAINS; RESISTANCE;
D O I
10.1016/j.ijmm.2020.151393
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacteria colonising the lungs of cystic fibrosis (CF) patients encounter high selective pressures. Hypermutation facilitates adaptation to fluctuating environments, and hypermutator strains are frequently isolated from CF patients. We investigated the prevalence of hypermutator isolates of Achromobacter spp. among patients affiliated with the CF Centre in Aarhus, Denmark. By exposure to rifampicin, the mutation frequency was determined for 90 isolates of Achromobacter spp. cultured from 42 CF patients; 20 infections were categorised as chronic, 22 as intermittent. The genetic mechanisms of hypermutation were examined by comparing DNA repair gene sequences from hypermutator and normomutator isolates. Achromobacter spp. cultured from 11 patients were categorised as hypermutators, and this phenotype was exclusively associated with chronic infections. Isolates of the Danish epidemic strain (DES) of Achromobacter ruhlandii cultured from patients from both Danish CF centres showed elevated mutation frequencies. The hypermutator state of Achromobacter spp. was most commonly associated with nonsynonymous mutations in the DNA mismatch repair gene mutS; a single clone had developed a substitution in the S-adenosyl-L-methionine-dependent methyltransferase putatively involved in DNA repair mechanisms, but not previously linked to the hypermutator phenotype. Hypermutation is prevalent among clinical isolates of Achromobacter spp. and could be a key determinant for the extraordinary adaptation and persistence of DES.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients
    Raso, Tiziana
    Bianco, Ornella
    Grosso, Bianca
    Zucca, Mario
    Savoia, Dianella
    APMIS, 2008, 116 (09) : 837 - 841
  • [42] Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
    A. Lambiase
    M. R. Catania
    M. del Pezzo
    F. Rossano
    V. Terlizzi
    A. Sepe
    V. Raia
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 973 - 980
  • [43] Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
    Lambiase, A.
    Catania, M. R.
    del Pezzo, M.
    Rossano, F.
    Terlizzi, V.
    Sepe, A.
    Raia, V.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (08) : 973 - 980
  • [44] Achromobacter xylosoxidans: Characterization of Strains in Brazilian Cystic Fibrosis Patients
    Pereira, Rosana H. V.
    Carvalho-Assef, Ana Paula
    Albano, Rodolpho M.
    Folescu, Tania W.
    Jones, Marcia C. M. F.
    Leao, Robson S.
    Marques, Elizabeth A.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (10) : 3649 - 3651
  • [45] Structured surveillance of Achromobacter, Pandoraea and Ralstonia species from patients in England with cystic fibrosis
    Coward, Amy
    Kenna, Dervla T. D.
    Woodford, Neil
    Turton, Jane F.
    Armstrong, Malcolm
    Auckland, Cressida
    Bowler, Ian
    Burns, Phillipa
    Cargill, James
    Carroll, Mary
    Flight, William
    Graver, Michelle
    Green, Heather
    Horner, Carolyne
    Jones, Andrew
    Jones, Andrew M.
    Jones, Graeme
    Mayell, Sarah
    Orendi, Jeorge
    Perry, Audrey
    Robb, Ali
    Tucker, Natasha
    Waine, David
    Winstanley, Trevor
    Withers, Nick
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (03) : 388 - 393
  • [46] Antimicrobial susceptibility of Achromobacter xylosoxidans (AXX) isolated from patients with cystic fibrosis (CF)
    Caillon, J
    Jacqueline, C
    Wuilleme, X
    Le Mabecque, V
    Miegeville, AF
    Haloun, A
    Potel, G
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S145 - S145
  • [47] High prevalence of inducible clindamycin resistance among Staphylococcus aureus isolates from patients with cystic fibrosis
    Moore, Zack S.
    Jerris, Robert C.
    Hifinski, Joseph A.
    JOURNAL OF CYSTIC FIBROSIS, 2008, 7 (03) : 206 - 209
  • [48] Epidemiology of Streptococcus agalactiae isolates from cystic fibrosis patients
    Eickel, V.
    Kahl, B.
    Spellerberg, B.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 296 : 109 - 109
  • [49] Clinical relevance of Scedosporium spp. and Exophiala dermatitidis in patients with cystic fibrosis: A nationwide study
    de Jong, C. C. M.
    Slabbers, L.
    Engel, T. G. P.
    Yntema, J. B.
    van Westreenen, M.
    Croughs, P. D.
    Roeleveld, N.
    Brimicombe, R.
    Verweij, P. E.
    Meis, J. F.
    Merkus, P. J.
    MEDICAL MYCOLOGY, 2020, 58 (07) : 859 - 866
  • [50] Chryseobacterium spp., a new opportunistic pathogen associated with cystic fibrosis?
    Guiu, Alba
    Buendia, Buenaventura
    Llorca, Laura
    Gomez Punter, Rosa Maria
    Giron, Rosa
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2014, 32 (08): : 497 - 501